Scientific Reports (Feb 2024)

Centromeric AA motif in KIR as an optimal surrogate marker for precision definition of alloimmune reproductive failure

  • Raquel Gil Laborda,
  • Edgard Rodríguez de Frías,
  • Nabil Subhi-Issa,
  • Elena Carrillo de Albornoz,
  • Elena Meliá,
  • Marcos Órdenes,
  • Victoria Verdú,
  • Juan Vidal,
  • Esther Suárez,
  • Isabel Santillán,
  • Daniel Ordóñez,
  • David Pintado-Vera,
  • Victoria González Villafáñez,
  • Ángel Lorenzo,
  • Manuel Fariñas,
  • Mario Rodríguez-Paíno,
  • María Núñez Beltrán,
  • Áurea García Segovia,
  • Ainhoa del Olmo,
  • Fernando Martín Cañadas,
  • Rosa Daurelio,
  • Alfonso de la Fuente,
  • José Manuel González Casbas,
  • Vega Cabezuelo,
  • Francisco Ros Berruezo,
  • Miguel Ángel Moreno Hidalgo,
  • Silvia Iniesta,
  • Beatriz Bueno,
  • Álvaro Martínez Acera,
  • Alexandra Izquierdo,
  • José Luis Vicario,
  • Miguel Fernández-Arquero,
  • Silvia Sánchez-Ramón

DOI
https://doi.org/10.1038/s41598-024-53766-x
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 10

Abstract

Read online

Abstract Throughout pregnancy, the decidua is predominantly populated by NK lymphocytes expressing Killer immunoglobulin-like receptors (KIR) that recognize human leukocyte antigen-C (HLA-C) ligands from trophoblast cells. This study aims to investigate the association of KIR-HLA-C phenotypes in couples facing infertility, particularly recurrent pregnancy loss (RPL) and recurrent implantation failure (RIF), in comparison to a reference population and fertile controls. This observational, non-interventional retrospective case–control study included patients consecutively referred to our Reproductive Immunology Unit from 2015 to 2019. We analyzed the frequencies of KIR and HLA-C genes. As control groups, we analyzed a reference Spanish population for KIR analysis and 29 fertile controls and their male partners for KIR and HLA-C combinations. We studied 397 consecutively referred women with infertility and their male partners. Among women with unexplained RPL (133 women) and RIF (176 women), the centromeric (cen)AA KIR genotype was significantly more prevalent compared to the reference Spanish population (p = 0.001 and 0.02, respectively). Furthermore, cenAA was associated with a 1.51-fold risk of RPL and a 1.2-fold risk of RIF. Conversely, the presence of BB KIR showed a lower risk of reproductive failure compared to non-BB KIR (OR: 0.12, p < 0.001). Women and their partners with HLA-C1C1/C1C1 were significantly less common in the RPL-Group (p < 0.001) and RIF-Group (p = 0.002) compared to the control group. Moreover, the combination of cenAA/C1C1 in women with C1C1 partners was significantly higher in the control group than in the RPL (p = 0.009) and RIF (p = 0.04) groups, associated with a 5-fold increase in successful pregnancy outcomes. In our cohort, the cenAA KIR haplotype proved to be a more accurate biomarker than the classic AA KIR haplotype for assessing the risk of RPL and RIF, and might be particularly useful to identify women at increased risk among the heterogeneous KIR AB or Bx population. The classification of centromeric KIR haplotypes outperforms classical KIR haplotypes, making it a better indicator of potential maternal–fetal KIR-HLA-C mismatch in patients.

Keywords